As the Group Product Director of Patient Experience in Oncology at Janssen Biotech, Jared understands the importance of supporting patients and the broader myeloma community, as well as raising awareness for this disease. Jared, who enjoys a strong base of fitness, kicked his cycling training into high gear to be part of the Red Rocks team in 2018. He is looking forward to the 2019 ride alongside the very patients and patient caregivers that he works to serve everyday at Janssen.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More